How environmental factors affect cell signaling in plants
Official title: Osmotic Regulation of a Peptide Ligand-Mediated Signaling
Funded at Rutgers the State Univ of Nj Camden · NIH-10908525 · Data updated 2026-11-12
This study looks at how certain tiny proteins that help plants communicate are affected by changes in their environment, like when they experience water stress, using a common plant called Arabidopsis. By understanding how these proteins help control the openings in plant leaves that allow gas exchange, the researchers hope to learn more about how similar processes might relate to health issues in humans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers the State Univ of Nj Camden NIH-funded |
| Lab location | 1 site (Camden, United States) |
| Project start | September 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $391,354 |
| NIH project number | 5R35GM151096-02 |
| Project ID | NIH-10908525 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with conditions linked to cell signaling abnormalities, such as certain cancers and metabolic disorders.
✕Less likely to help
Patients with conditions unrelated to cell signaling or those not affected by environmental factors may not receive direct benefits from this research.
What this research studies
This research investigates how peptide ligands, which are crucial for cell communication, are influenced by environmental conditions, particularly osmotic stress. By studying the model plant Arabidopsis thaliana, the research aims to understand the signaling pathways that regulate stomatal development, which are essential for gas exchange in plants. The project utilizes experimental techniques to analyze how these pathways adapt to changes in the environment, providing insights that could be relevant to human health and disease. The findings may help elucidate the mechanisms behind various diseases linked to dysregulated cell signaling.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for managing diseases related to cell signaling dysregulation in humans.
How similar studies have gone: Other research has shown success in understanding cell signaling pathways in plants, suggesting that this approach may yield valuable insights for human health.
Where this research is happening
-
Rutgers the State Univ of Nj Camden
Camden, United States Active
Researchers
- Principal investigator: Qi, Xingyun — Rutgers the State Univ of Nj Camden
- Study coordinator: Qi, Xingyun
Related research
Other NIH-funded projects on the same topics.
-
Computational analysis of transcriptome rearrangements in SARS-CoV-2
A computer-based project from Rutgers-Camden will look at how the coronavirus may rearrange its RNA to create new proteins, which could inform future drugs and vaccines.
-
Understanding how mitochondria handle stress
This research explores how a molecule called polyphosphate helps mitochondria, the energy factories in our cells, cope with stress that happens in many human diseases.
-
Detecting hidden RNA rearrangements in the COVID‑19 virus
This project builds free computer tools to find unusual RNA rearrangements in the COVID‑19 virus that could point to new targets for treatments or vaccines for people affected by COVID‑19.
-
Improving gene editing in blood stem cells using nanoparticles
This study is looking at a new way to help deliver a gene-editing tool called CRISPR to blood stem cells, which could lead to better treatments for genetic blood disorders like sickle cell disease.
-
Investigating how mitochondrial polyphosphate affects stress responses in mammals.
This study is looking at how a substance called inorganic polyphosphate helps our cells deal with stress, especially in the tiny energy factories called mitochondria, and it could lead to new treatments for diseases related to mitochondrial problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.